Search all medical codes

Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

HCPCS code

Name of the Procedure:

Dexamethasone, Inhalation Solution, Compounded Product, Administered Through DME, Unit Dose Form (HCPCS Code J7638)
Common Names: Inhaled Dexamethasone

Summary

Dexamethasone Inhalation Solution is a medication used to reduce inflammation in the lungs. This solution is administered via a specialized device called durable medical equipment (DME) that allows the medication to be inhaled directly into the respiratory system.

Purpose

This treatment is primarily used to address inflammatory conditions of the lungs, such as asthma or chronic obstructive pulmonary disease (COPD). The goal is to reduce lung inflammation, alleviate symptoms like wheezing and shortness of breath, and improve overall respiratory function.

Indications

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other inflammatory lung conditions Suitable for patients experiencing moderate to severe respiratory symptoms that are not controlled by other medications.

Preparation

  • Patients should inform their healthcare provider of all current medications and allergies.
  • No fasting or specific preparations are typically required.
  • A thorough medical history and physical examination will be performed.

Procedure Description

  1. Preparation of the Solution: The compounded dexamethasone solution is prepared in a sterile environment.
  2. Setting Up the DME: The durable medical equipment, often a nebulizer or similar device, is assembled and prepared.
  3. Administration: The patient inhales the medication through a mask or mouthpiece connected to the DME. The device converts the liquid solution into a fine mist that can be easily inhaled into the lungs.
  4. Monitoring: Healthcare professionals may monitor the patient for any immediate reactions.

Duration

The procedure typically takes about 10-20 minutes.

Setting

This procedure can be performed in various settings, including:

  • Hospitals
  • Outpatient clinics
  • At home under the guidance of healthcare professionals

Personnel

  • Physicians or Respiratory Therapists for prescribing and initial set-up
  • Nurses for administering and monitoring the procedure

Risks and Complications

  • Common: Sore throat, dry mouth, coughing
  • Rare: Allergic reactions, changes in blood sugar levels (particularly in diabetics) Adverse effects are generally manageable with prompt medical attention.

Benefits

  • Reduction in lung inflammation
  • Alleviation of symptoms like wheezing and shortness of breath
  • Improvement in overall respiratory function Benefits are usually noticed within a few hours to days.

Recovery

  • Patients can resume normal activities immediately after the procedure.
  • Follow-up appointments may be scheduled to assess the effectiveness of the treatment and adjust dosage if necessary.

Alternatives

  • Oral or Systemic Steroids: These can also reduce lung inflammation but may have more systemic side effects.
  • Bronchodilators: Medications that help relax the muscles around the airways.
  • Biologic Therapies: Used for severe cases of asthma. Each alternative has its specific benefits and drawbacks, particularly in terms of side effects and long-term use.

Patient Experience

  • During the Procedure: Patients might feel a cool mist as they inhale the medication; some may experience a slight aftertaste.
  • After the Procedure: Most patients feel normal; however, minor throat irritation or hoarseness can occur. Pain management is typically not an issue with this non-invasive procedure. Comfort measures include maintaining hydration and possibly using a humidifier.

Similar Codes